Clinical Trials Directory

Trials / Conditions / Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7

Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7

6 registered clinical trials studyying Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 — 1 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingPembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer
NCT03468218
Emory UniversityPhase 2
Active Not RecruitingTesting the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Canc
NCT02567422
National Cancer Institute (NCI)Phase 1
RecruitingTesting Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy
NCT01810913
National Cancer Institute (NCI)Phase 2 / Phase 3
CompletedLenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer
NCT01254617
National Cancer Institute (NCI)Phase 1
CompletedCombination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recur
NCT01064479
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingChemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squam
NCT00588770
National Cancer Institute (NCI)Phase 3